Literature DB >> 31182350

Chronic Systemic Inflammation Is Associated With Symptoms of Late-Life Depression: The ARIC Study.

Natalia Sonsin-Diaz1, Rebecca F Gottesman2, Elizabeth Fracica3, Jeremy Walston4, B Gwen Windham5, David S Knopman6, Keenan A Walker7.   

Abstract

OBJECTIVE: The current study examined how the pattern of systemic inflammation in the decades leading up to late-life relates to depression symptoms in older adults.
METHODS: Within the Atherosclerosis Risk in Communities Study, we measured high-sensitivity C-reactive protein (CRP), a nonspecific marker of systemic inflammation, at three visits: 21 years and 14 years before, and concurrent with the assessment of depression symptoms, defined using the 11-item Center for Epidemiologic Studies Depression (CESD) scale. We categorized participants into one of four groups based on their 21-year longitudinal pattern of elevated (≥3 mg/L) versus low (<3 mg/L) CRP (stable low; unstable low; unstable elevated; stable elevated). Analyses excluded participants with suspected depression during midlife.
RESULTS: A total of 4,614 participants were included (age at CESD assessment: 75.5 [SD: 5.1]; 59% female; follow-up time: 20.7 years [SD: 1.0]). Compared to participants who maintained low CRP levels (stable low), participants who had elevated CRP at two of three visits (unstable elevated; ß = 0.09; 95% confidence interval [CI]: 0.02, 0.17) and participants who maintained elevated CRP at all three visits (stable elevated; ß = 0.13; 95% CI: 0.05, 0.21) had greater depression symptoms as older adults, after adjusting for confounders. After excluding participants with late-life cognitive impairment, only participants with stable elevated CRP demonstrated significantly greater late-life depression symptoms. In a secondary analysis, stable elevated CRP was associated with increased risk for clinically significant late-life depression symptoms.
CONCLUSION: Chronic or repeated inflammation in the decades leading up to older adulthood is associated with late-life depression, even in the context of normal cognition.
Copyright © 2019 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; cognition; dementia; depression; immunology

Year:  2019        PMID: 31182350      PMCID: PMC6868307          DOI: 10.1016/j.jagp.2019.05.011

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  39 in total

Review 1.  The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.

Authors:  Marieke Wichers; Michael Maes
Journal:  Int J Neuropsychopharmacol       Date:  2002-12       Impact factor: 5.176

Review 2.  Peculiarities of geriatric psychiatry: a focus on aging and depression.

Authors:  Jerson Laks; Eliasz Engelhardt
Journal:  CNS Neurosci Ther       Date:  2010-09-28       Impact factor: 5.243

3.  The association of mid-to late-life systemic inflammation with white matter structure in older adults: The Atherosclerosis Risk in Communities Study.

Authors:  Keenan A Walker; B Gwen Windham; Melinda C Power; Ron C Hoogeveen; Aaron R Folsom; Christie M Ballantyne; David S Knopman; Elizabeth Selvin; Clifford R Jack; Rebecca F Gottesman
Journal:  Neurobiol Aging       Date:  2018-04-04       Impact factor: 4.673

4.  Midlife Systemic Inflammation Is Associated With Frailty in Later Life: The ARIC Study.

Authors:  Keenan A Walker; Jeremy Walston; Rebecca F Gottesman; Anna Kucharska-Newton; Priya Palta; B Gwen Windham
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-02-15       Impact factor: 6.053

Review 5.  Inflammation, C-reactive protein, and atherothrombosis.

Authors:  Paul M Ridker; Josh D Silvertown
Journal:  J Periodontol       Date:  2008-08       Impact factor: 6.993

6.  Depressive symptomatology and vital exhaustion are differentially related to behavioral risk factors for coronary artery disease.

Authors:  M S Kopp; P R Falger; A Appels; S Szedmák
Journal:  Psychosom Med       Date:  1998 Nov-Dec       Impact factor: 4.312

7.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

8.  Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States.

Authors:  Deborah S Hasin; Aaron L Sarvet; Jacquelyn L Meyers; Tulshi D Saha; W June Ruan; Malka Stohl; Bridget F Grant
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

9.  Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study.

Authors:  Keenan A Walker; Melinda C Power; Ron C Hoogeveen; Aaron R Folsom; Christie M Ballantyne; David S Knopman; B Gwen Windham; Elizabeth Selvin; Clifford R Jack; Rebecca F Gottesman
Journal:  Stroke       Date:  2017-11-03       Impact factor: 7.914

10.  Late-life depression and quality of life in a geriatric evaluation and management unit: an exploratory study.

Authors:  Jui-Hung Lin; Min-Wei Huang; Deng-Wu Wang; Yi-Ming Chen; Chu-Sheng Lin; Yi-Jing Tang; Shu-Hui Yang; Hsien-Yuan Lane
Journal:  BMC Geriatr       Date:  2014-06-18       Impact factor: 3.921

View more
  9 in total

1.  Links Between Inflammation, Mood, and Physical Function Among Older Adults With HIV.

Authors:  Heather M Derry; Carrie D Johnston; Chelsie O Burchett; Mark Brennan-Ing; Stephen Karpiak; Yuan-Shan Zhu; Eugenia L Siegler; Marshall J Glesby
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-01-12       Impact factor: 4.077

2.  Epigenetic age is associated with baseline and 3-year change in frailty in the Canadian Longitudinal Study on Aging.

Authors:  Chris P Verschoor; David T S Lin; Michael S Kobor; Oxana Mian; Jinhui Ma; Guillaume Pare; Gustavo Ybazeta
Journal:  Clin Epigenetics       Date:  2021-08-23       Impact factor: 6.551

3.  Changes in Hypertension Control in a Community-Based Population of Older Adults, 2011-2013 to 2016-2017.

Authors:  Kathryn Foti; Kunihiro Matsushita; Silvia Koton; Keenan A Walker; Josef Coresh; Lawrence J Appel; Elizabeth Selvin
Journal:  Am J Hypertens       Date:  2021-06-22       Impact factor: 3.080

Review 4.  Gene-disease association study of tumor necrosis factor-α G-308A gene polymorphism with risk of major depressive disorder: A systematic review and meta-analysis.

Authors:  Xin Wang; Hongxiu Zhang; Xianling Cao; Wei Shi; Xiaoyu Zhou; Qian Chen; Ke Ma
Journal:  Brain Behav       Date:  2020-04-19       Impact factor: 2.708

Review 5.  C-Reactive Protein as a Biomarker for Major Depressive Disorder?

Authors:  Laura Orsolini; Simone Pompili; Silvia Tempia Valenta; Virginio Salvi; Umberto Volpe
Journal:  Int J Mol Sci       Date:  2022-01-30       Impact factor: 5.923

6.  Serum Cortisol, Nesfatin-1, and IL-1β: Potential Diagnostic Biomarkers in Elderly Patients with Treatment-Resistant Depression.

Authors:  Xiaoping Wu; Biao Dai; Fanfan Yan; Yang Chen; Yayun Xu; Qingrong Xia; Xulai Zhang
Journal:  Clin Interv Aging       Date:  2022-04-21       Impact factor: 3.829

7.  Improving Mental Health Services: A 50-Year Journey from Randomized Experiments to Artificial Intelligence and Precision Mental Health.

Authors:  Leonard Bickman
Journal:  Adm Policy Ment Health       Date:  2020-09

8.  Head injury and 25-year risk of dementia.

Authors:  Andrea L C Schneider; Elizabeth Selvin; Lawrence Latour; L Christine Turtzo; Josef Coresh; Thomas Mosley; Geoffrey Ling; Rebecca F Gottesman
Journal:  Alzheimers Dement       Date:  2021-03-09       Impact factor: 16.655

9.  Age-Related Hearing Loss, Late-Life Depression, and Risk for Incident Dementia in Older Adults.

Authors:  Katharine K Brewster; Mei-Chen Hu; Sigal Zilcha-Mano; Alexandra Stein; Patrick J Brown; Melanie M Wall; Steven P Roose; Justin S Golub; Bret R Rutherford
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-04-30       Impact factor: 6.591

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.